Pfizer Vaxx Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)

Pfizer Vaxx Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Pfizer Vaxx Nonclinical Evaluation of BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
847 Downloads

FOI report on Pfizer mRNA Covid-19 Vaccine. Read the chart on Page 45 for test results, including amount of radioactivity observed.

The animal studies were of short term; long term immunity was not assessed. The sponsor indicated that long term immunity would be addressed by human data. 

Size: 2,583KB